Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00256568 · ClinicalTrials.gov registry record
Outpatient Prescription Errors: Detection, Analysis, and Impact on Safety
A clinical trial, sponsored by University of Vermont.
- Completed
- Registry status
- 103
- Enrollment target
NCT00256568: Completed study, sponsored by University of Vermont.
NCT00256568 is a clinical trial that has completed, run by University of Vermont. The registered enrollment target is 103 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00256568 has completed, sponsored by University of Vermont.
- COMPLETED
- Registry status
- 103 participants
- Enrollment target
Study Summary
The purpose of this study is to better understand outpatient prescribing errors through clinic and pharmacy-based error reporting systems.
Interventions
- BEHAVIORAL reporting system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2003-09 |
| Est. Completion | 2008-08 |
What the finished NCT00256568 record still lists
NCT00256568 is an observational study that tracks outcomes without assigning an intervention. The registered 103 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which reporting system is the first listed.
NCT00256568 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00256568 about?
NCT00256568 is a clinical study titled "Outpatient Prescription Errors: Detection, Analysis, and Impact on Safety". The purpose of this study is to better understand outpatient prescribing errors through clinic and pharmacy-based error reporting systems.
What is the current status of trial NCT00256568?
This trial is currently completed. The enrollment target is 103 participants. The study started on 2003-09. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00256568?
The interventions under investigation include: reporting system (BEHAVIORAL).
Who is sponsoring clinical trial NCT00256568?
This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04690348 · 103 participants · Phase 2
Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study
- NCT05282277 · 103 participants · Phase 4
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
- NCT05566769 · 103 participants · NA
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
- NCT05834478 · 103 participants · Phase 3
Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia